Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Unknown 3Completed 3Terminated 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Sarcoma 1

Conditions

Breast Neoplasms 2Hemangiosarcoma 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × genexol-PM × Clear all
NCT03512834 2018-07-11

ASAP

Dong-A University Hospital

Phase 2 Unknown
32 enrolled
Sarcoma

Hemangiosarcoma

NCT01784120 2016-02-10

A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer

Gachon University Gil Medical Center

Phase 2 Unknown
48 enrolled
Breast

Breast Neoplasms

NCT00912639 2009-06-16

A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer

Korean Breast Cancer Study Group

Phase 4 Unknown
90 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡